Skip to main content

Table 4 Comparison of thrombotic markers between healthy individuals and cervical cancer patients

From: Development of a thrombin-antithrombin complex detection kit and study in venous thromboembolism complicated by cervical cancer

Thrombosis markers

Control Group (n = 80)

Cervical cancer group (n = 177)

Z Value

P Value

t-PAIC (ng/mL)

4.49 (3.04 ~ 7.21)

5.82 (4.07 ~ 7.94)

−2.508

0.012

TAT (ng/mL)

3.27 (2.65 ~ 3.91)

10.43 (6.61 ~ 13.87)

−11.251

< 0.001

TM (TU/mL)

6.27 (4.49 ~ 8.44)

5.57 (4.02 ~ 10.92)

−0.177

0.860

PIC (ng/mL)

0.32 (0.20 ~ 0.50)

0.70 (0.44 ~ 0.95)

−7.839

< 0.001

  1. Abbreviation: VTE Stomach cancer, t-PAIC Tissue plasminogen activator inhibitor complex, TAT Thrombin-antithrombin complex, TM Thrombomodulin, PIC α2-plamininhibitor-plasmin complex
  2. *P < 0.05 considered statistically significant